Antifungal activity of natural compounds against Candida species isolated from HIV-positive patients  by Oro, Débora et al.
HOSTED BY Contents lists available at ScienceDirect
Asian Pac J Trop Biomed 2015; 5(9): 781–784 781Asian Paciﬁc Journal of Tropical Biomedicine
journal homepage: www.elsevier.com/locate/apjtbShort communication http://dx.doi.org/10.1016/j.apjtb.2015.07.011*Corresponding author: Patrı´cia da Silva Malheiros, Hygiene and Food
Microbiology Laboratory, Department of Food Sciences, Food Science and
Technology Institute, Federal University of Rio Grande do Sul, ICTA/UFRGS, Porto
Alegre, RS, Brazil.
Tel: +55 513308 7861
E-mail: patricia.malheiros@ufrgs.br
Peer review under responsibility of Hainan Medical University.
Foundation Project: Supported by University of Western Santa Catarina, West of
Sao Miguel, Santa Catarina, Brazil.
2221-1691/Copyright © 2015 Hainan Medical University. Production and hosting by Elsevier (Singapore) Pte Ltd. This is an open
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Antifungal activity of natural compounds against Candida species isolated from
HIV-positive patientsDe´bora Oro1, Andre´ia Heissler1, Eliandra Mirlei Rossi1,2, Diane Scapin1, Patrı´cia da Silva Malheiros2*,
1Everton Boff
1Microbiological Research and Diagnostic Laboratory, Department of Biological and Health Sciences,
University of Western Santa Catarina Sao Miguel Oeste, SC, Brazil
2Hygiene and Food Microbiology Laboratory, Department of Food Sciences, Food Science and Technology Institute,
Federal University of Rio Grande do Sul, ICTA/UFRGS, Porto Alegre, RS, BrazilARTICLE INFO
Article history:
Received 17 Apr 2015
Received in revised form 15 May,
2nd revised form 18 May 2015
Accepted 12 Jun 2015
Available online 7 Aug 2015
Keywords:
Candida sp.
Essential oils
Honey
HIV
SusceptibilityABSTRACT
Objective: To evaluate the antifungal effect of Cinnamomum zeylanicum
(C. zeylanicum) and Melaleuca alternifolia essential oils and honey against strains of
Candida sp. from HIV-positive patients in order to subsidize new therapeutic strategies
for candidiasis.
Methods: The study evaluated the antifungal effect of natural antimicrobials against 30
strains of Candida sp. isolated from oral cavities in HIV-infected patients. Then, they
were compared to the action of ﬂuconazole and amphotericin B. Antifungal susceptibility
was evaluated by the broth macrodilution technique and the minimum inhibitory con-
centration and the minimum fungicidal concentration were determined.
Results: Among all antifungals evaluated in this study, amphotericin B was the one
showing the best results; however, all compounds studied here showed inhibitory ac-
tivities against isolates of Candida sp. Honey (0.0313–64 mg/mL) demonstrated fungi-
static activity inhibiting 70% of the isolates. C. zeylanicum essential oil (0.0313–64 mg/
mL) inhibited 93.3% of the Candida strains and Melaleuca alternifolia essential oil
(0.0313–64 mg/mL) was able to inhibit 73.3% of them.
Conclusions: Therefore, all natural compounds evaluated in this study, especially
C. zeylanicum essential oil, may become promising agents for oral candidiasis therapy
including in HIV-positive patients.1. Introduction
Oral candidiasis is the most common clinical manifestation in
patients infected with HIV, being a sign of immune imbalance
that usually heralds the transition to AIDS. In these patients,
Candida albicans (C. albicans) is the species responsible for
most infections [1–4].
The increased resistance to available antifungal agents and
the toxicity contained in some of these drugs has reduced theeffectiveness of treatments [2,4,5]. Therefore, it is very important
for the discovery of new antifungal agents, in order to widen the
spectrum of activity against Candida and ﬁght strains resistant to
conventional antifungal drugs such as amphotericin B and
ﬂuconazole.
In this context, many natural products have shown to be
alternative therapies for the treatment of candidiasis [5,6]. Among
these natural products, essential oils are known to have
antimicrobial properties; however, only in recent years the
science has elucidated the action mechanism of these
compounds.
Melaleuca alternifolia (M. alternifolia), a native plant from
Australia and commonly known as tea tree oil, and Cinnamo-
mum zeylanicum (C. zeylanicum), a plant found in Sri Lanka and
southern parts of India, have both shown potential antimicrobial
action against a wide variety of bacteria and fungi [7,8].access article under the CC BY-NC-ND
Table 1
Average from MIC and MFC of the studied compounds against non-
C. albicans (mg/mL).
Substance MIC MFC
Fluconazole 5.80 ± 0.80 13.33 ± 1.00
Amphotericin B 0.62 ± 0.50 6.04 ± 0.80
C. zeylanicum 3.39 ± 0.60 8.88 ± 0.90
M. alternifolia 4.84 ± 0.50 32.00 ± 1.00
Honey 8.04 ± 0.90 NFE
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the world for its anti-microbial properties [9]. Researches have
shown the antifungal potential of honey against Candida sp.
[10]. However, just few ones have been made studying the
inhibition of Candida strains isolated from HIV-infected
patients.
In this context, the objective of this study was to evaluate the
antifungal effects of C. zeylanicum and M. alternifolia essential
oils and honey against strains of Candida sp. from HIV-positive
patients in order to subsidize new therapeutic strategies for
candidiasis.
2. Materials and methods
2.1. C. albicans isolates
The study isolated 30 strains of Candida sp. from the oral
cavity of HIV-infected patients. These yeasts were subjected to
the germ tube technique identifying presumptive species of
C. albicans. For the tube germ test, a colony of each strain was
transferred to another one containing 0.5 mL of 1% peptone
water, which was incubated at 37 C for 2–3 h. After that, the
suspension was examined under optical microscope (1 000×) in
order to visualize the germ tube formation.
2.2. Inoculum
The inoculum was prepared from 48-h cultures in Sabo-
uraud dextrose agar supplemented with chloramphenicol
(Difco, France), stopping up the fungal cells in sterile
distilled water. The cell density was adjusted with a spec-
trophotometer (Biospectro) at wavelength of 530 nm in order
to obtain the transmittance of 0.5 MacFarland scale. There-
after, the inoculum was diluted in RPMI 1640 (Sigma
Chemical, St. Louis), which resulted in a ﬁnal concentration
of 2.5 × 103 cells/mL2.
2.3. Essential oils, honey and antifungal drugs
Essential oils were purchased from the Petite Marie Fine
Chemicals LTD company (Itaquaquecetuba-SP). Honey was
purchased in a supermarket (Sulmel®, Xaxim-SC) and it was
used in pure form. All the composts were diluted in RPMI 1640
medium (Sigma Chemical) in order to offer ﬁnal concentrations
from 0.031 3 mg/mL to 64 mg/mL.
The suspension of amphotericin B and ﬂuconazole were
prepared according to the protocol M27-A2 [11]. The ﬁnal
concentrations for amphotericin B ranged from 0.031 3 mg/mL
to 16 mg/mL and, for the ﬂuconazole, ranged from 0.125 mg/
mL to 64 mg/mL.
2.4. Susceptibility tests
The minimum inhibitory concentration (MIC) was performed
through broth macro-dilution technique [11]. For this, 100 mL
aliquots were added to each concentration of test substance
(honey and essential oils or antifungal drugs) and 100 mL of
inoculum in sterile test tubes, which were incubated at 36 C
for 24–48 h. All tests were performed in triplicate.
The minimum fungicidal concentration (MFC) determination
was obtained by transferring 100 mL of each concentration thatinhibited the fungal growth to the surface of Sabouraud agar
supplemented with chloramphenicol (Difco). After incubating
them for 48 h, the MFC was deﬁned as the lowest concentration
of drug capable of causing the death to 100% of fungal cells.
This was demonstrated by the absence of colonies in plate [11].
According to the Clinical And Laboratory Standards Institute
[11], the strains is sensitive to ﬂuconazole if MIC  8 mg/mL,
intermediate or susceptible dose-dependent to MIC from 16 to
32 mg/mL and it is resistant to MIC  64 mg/mL. Breakpoints
have not been established for amphotericin B during the inter-
pretation of results. However, according to data from the Clin-
ical and Laboratory Standards Institute [11], when MIC > 1 mg/
mL for Candida sp., it is likely that the isolate is resistant to this
drug.
2.5. Statistical analysis
Data on inhibitory effects of essential oils, honey, ﬂucona-
zole and amphotericin B on Candida spp. growth were subjected
to analysis of variance (ANOVA) and paired t-tests, using SPSS
statistical program, version 17.0. A signiﬁcant difference when
P < 0.05 was considered for these tests.
3. Results
In this study, from 30 Candida strains collected from
oropharyngeal HIV-positive patients, 22 (73.3%) of them
showed positive in germ tube test, indicating the presence of
C. albicans.
The amphotericin B demonstrated greater effectiveness
than ﬂuconazole inhibiting 100% of the evaluated Candida
strains at least in one of the concentrations (0.031 3–16 mg/
mL), and the fungicidal effect was observed in 93.3% of the
samples. Fluconazole also inhibited 100% of Candida strains
at least in one of the concentrations (0.125–64 mg/mL).
However, the fungicidal effect was seen in only 20% of the
samples.
In this sense, other alternatives are necessary to control
candidiase infection such as the use of essential oils.
C. zeylanicum essential oil (0.031 3–64 mg/mL) inhibited 93.3%
of the Candida strains evaluated in this study and M. alternifolia
essential oil (0.031 3–64 mg/mL) was able to inhibit 73.3%.
Nevertheless, the fungicidal effect of essential oils was less than
the fungistatic one showing percentages of 76.7% for
C. zeylanicum and 36.7% for M. alternifolia.
The honey (0.031 3–64 mg/mL) was able of inhibit 70% of
Candida isolates, although it showed no fungicidal effects
(Table 1), and its fungistatic effect was lower compared to both
assessed essential oils.NFE: No fungicide effect.
Table 2
Average from MIC and MFC of the studied compounds against
C. albicans (mg/mL).
Substance MIC MFC
Fluconazole 3.26 ± 0.80 42.67 ± 0.90
Amphotericin B 0.66 ± 0.30 6.61 ± 0.80
C. zeylanicum 10.45 ± 1.00 16.43 ± 1.20
M. alternifolia 20.03 ± 0.50 25.33 ± 0.80
Honey 14.25 ± 0.80 NFE
NFE: No fungicide effect.
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essential oil was of 10.45 mg/mL to C. albicans. Also using
C. zeylanicum essential oil, Unlu et al. found higher MIC values,
i.e. of 0.07 mg/mL and 1.12 mg/mL for two C. albicans strains
[12], demonstrating the high variability of sensitivity between
these different strains.
To M. alternifolia essential oil, it was found average MIC of
20.03 mg/mL to C. albicans (Table 2) and 4.84 mg/mL to non-
C. albicans (Table 1). Rosato et al. found a MIC between 1.75
and 3.5 mg/mL in M. alternifolia oil to different Candida strains
[13] and Thosar et al. found a MIC of 0.5 mL/mL to C. albicans
strains using the same oil [14].
4. Discussion
Oral candidiasis is an opportunistic infection commonly
found in HIV-positive patients. It leads to reduction in quality of
life and increased mortality. C. albicans has been shown as a
widespread species in HIV/AIDS patients [1,3]. The ﬁndings of
this work show that although the frequency of non-C. albicans
species is increasing, C. albicans remains the most prevalent
species in several cities of the world [1].
Amphotericin B and ﬂuconazole are important drugs used in
the candidiasis treatment. Fluconazole is usually the ﬁrst choice
drug for systemic infection; however, studies have shown the
increase of Candida strains resistant to this drug [1]. Others
works also found that C. albicans isolates were more sensible
to amphotericin B than ﬂuconazole [2], including HIV-infected
patients [15].
The differences between the fungicidal effect of amphotericin
B and ﬂuconazole may be caused by their distinct action
mechanisms. While amphotericin B action is based on the for-
mation of pores in the fungal cell membrane, altering perme-
ability becomes excellent to destroy the cell, and ﬂuconazole
inhibits the biosynthesis of ergosterol, an essential component of
fungal cell plasma membrane, causing only the infeasibility of
this cell [2]. Furthermore, the indiscriminate use of ﬂuconazole
may have contributed to the increased number of strains
resistant to this antifungal.
Besides, the results found in this study conﬁrm that the
antifungal properties assigned to honey make it a promising
agent for the treatment of oral candidiasis [10,16]. These results
are important, especially if compared to other ones in which
the MIC ranged from 38% to 46% [10,17].
The MIC results shown in Tables 1 and 2 allow us to note
that the yeast classiﬁed as non-C. albicans species had mean a
MIC lower than C. albicans, except for the ﬂuconazole. These
data demonstrate that non-C. albicans strains are more sensitiveto the tested substances when compared to C. albicans. Overall,
the average MFC was also lower for non-C. albicans than for
C. albicans. Although, such results can be inﬂuenced by the
number of samples, it has been found greater amount of
C. albicans (22 strains).
Comparing all antifungals studied here, it was possible to
note that amphotericin B showed the best performance against
the Candida isolates. Fluconazole showed better effects than
M. alternifolia oil; nevertheless, its fungistatic action was similar
to C. zeylanicum essential oil and honey. Among the evaluated
essential oils, C. zeylanicum showed signiﬁcantly better effects
when compared to M. alternifolia oil.
The results also showed that amphotericin B is an excellent
antifungal to control Candida sp., since it showed the best re-
sults among all compounds studied. However, the toxicity
attributed to this drug limits its use, thus, it is necessary to apply
alternative therapies when assisting patients in the treatment of
candidiasis. Thus, the synergistic effect of some essential oils,
such as M. alternifolia, can be an interesting alternative when
used in combination with amphotericin B [13].
Accordingly, the studied compounds showed a signiﬁcant
antifungal activity against Candida sp., strengthening the role of
folk medicine during the treatment of candidiasis. This demon-
strates the feasibility of using these compounds as adjuvants for
the treatment of oral candidiasis, especially in HIV patients,
making them as promising for the treatment of this type of
fungal infection.
All evaluated natural compounds, i.e. C. zeylanicum and
M. alternifolia essential oil and honey, showed antifungal effects
against Candida species isolated from HIV-positive patients.
Moreover, the C. zeylanicum essential oil has proven to have
higher antifungal activity and it needs further investigation to
evaluate its feasibility in clinical applications for the treatment of
superﬁcial candidiasis, especially in HIV-positive patients.
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